Reduces oxidative stress Neutralizes free radicals, supports the immune system and detoxifies the body
(2012) demonstrated: Statistically significant reductions in visceral adipose tissue of approximately 1518% over 26 weeks compared to placebo Meaningful increases in IGF-1 levels Improvements in triglyceride profiles in some patient subgroups Effects were partially reversed upon discontinuation, suggesting that sustained benefit requires ongoing therapy The consistency of the VAT reduction finding across multiple trials is what anchors tesamorelin's clinical utility
In terms of effect size, improvements with Pycnogenol have been medium not as huge as high-dose medication, but clearly noticeable
These human clinical trials provide compelling evidence that astaxanthin delivers meaningful skin benefits in real-world conditions, not just theoretical or laboratory settings
Retrieved from Lacombe, V., Chabrun, F., Lacout, C., Ghali, A., Capitain, O., Patsouris, A., et al